人工智能对比剂:深度学习在神经放射学中减少钆对比剂的应用
本文综述深度学习在神经放射学中减少钆对比剂的应用,涵盖低剂量和零剂量两种策略,讨论其优势、局限性、输出评估挑战及临床适用性进展。
要点
- 深度学习可用于减少或替代钆对比剂,分低剂量与零剂量两种策略
- 零剂量方法完全替代钆对比剂,低剂量方法减少用量
- 输出评估和临床转化仍面临挑战
研究设计与样本
- 综述性文章,旨在突出精选研究并讨论深度学习方法的优势与局限性。
临床应用与阅片要点
- 在神经放射学中,可关注深度学习用于减少钆对比剂剂量或替代对比剂的研究进展。
- 区分低剂量和零剂量方法,注意评估其输出和临床适用性。
局限性
- 综述文章,未提供原始研究数据。
- 深度学习方法的输出评估存在挑战。
- 临床适用性仍在进展中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Deep learning approaches are playing an ever-increasing role throughout diagnostic medicine, especially in neuroradiology, to solve a wide range of problems such as segmentation, synthesis of missing sequences, and image quality improvement. Of particular interest is their application in the reduction of gadolinium-based contrast agents, the administration of which has been under cautious reevaluation in recent years because of concerns about gadolinium deposition and its unclear long-term consequences. A growing number of studies are investigating the reduction (low-dose approach) or even complete substitution (zero-dose approach) of gadolinium-based contrast agents in diverse patient populations using a variety of deep learning methods. This work aims to highlight selected research and discusses the advantages and limitations of recent deep learning approaches, the challenges of assessing its output, and the progress toward clinical applicability distinguishing between the low-dose and zero-dose approach.
引用
- Haase, Pinetz, Kobler, et al. Artificial Contrast: Deep Learning for Reducing Gadolinium-Based Contrast Agents in Neuroradiology. Invest Radiol. 2023. PMID: 36822654. doi:10.1097/RLI.0000000000000963
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。